**For Health Care Professionals and Staff ONLY**

Covid Testing is Divided into Two Categories: Antigen and Antibody

Serology testing can play a critical role in the fight against Covid-19 by helping health care professionals identify individuals who have antibodies to be Sars-CoV-2 virus and have developed an adaptive immune response.

In the future, this may potentially be used to help determine, together with other clinical data, whether these individuals may be less susceptible to infection.

At this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity. In addition, these test results can aid in determining who may be eligible to donate a part of their blood called convalescent plasma, which may serve as a possible treatment for those who are seriously ill from COVID-19.

Testing of COVID-19 IgM and IgG antibodies is an effective method for rapid diagnosis of COVID-19 infection.

The rapid COVID-19 antigen test is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) swab specimens directly from individuals who are suspected of COVID-19 by their health care provider.

The Healgen Antigen Test is intended to aid in the rapid diagnosis is SARS-CoV-2 infections.

Ted Moffly is the founder and former CFO of Hygea, now NeighborMD, a large group practice in the Southeastern US. Hygea was one of the largest primary care practice networks in Georgia and Florida with over 100 direct primary care providers including clinical cardiologists and 3500 IPA providers. Ted has an MBA in finance from the University of Chicago.

A 10% product discount will be offered to those who register for the download.